Award

Purchase of Apheresis Spectra Optia machines with maintenance and consumables

NHS WALES SHARED SERVICES PARTNERSHIP

This public procurement record has 2 releases in its history.

Summary of the contracting process

The NHS Wales Shared Services Partnership, based in Cardiff, UK, is seeking to award a contract for the purchase of three Apheresis Spectra Optia machines with maintenance and consumables. The procurement stage is complete, and the deadline for this tender has passed. The procurement is in the health industry category.

This tender presents a lucrative opportunity for businesses specialising in the supply and maintenance of medical equipment, particularly those with experience in apheresis technology. The purchasing organisation, NHS Wales Shared Services Partnership, values reliability and accuracy in the equipment due to the specialised medical procedures it supports. The procurement method used was an award procedure without prior publication of a call for competition.

Find more tenders on our Open Data Platform.
How relevant is this notice?

D3 Tenders Premium

Win More Public Sector Contracts

AI-powered tender discovery, pipeline management, and market intelligence — everything you need to grow your public sector business.

Notice Title

Purchase of Apheresis Spectra Optia machines with maintenance and consumables

Notice Description

NHS Wales Shared Services Partnership who are hosted by Velindre NHS Trust acting on behalf of Cardiff and Vale University Local Health Board wish to inform the market that they intend to award a contract for the purchase of three Apheresis Spectra Optia machines with maintenance and consumables.

Lot Information

Lot 1

The South Wales Blood and Marrow Transplant Programme (SWBMT) serves adults and children within the catchment area of mid, west and south Wales, comprising six of the seven Welsh Local Health Boards (LHBs), with a combined population of approximately 2.4 million and accounting for over three-quarters of the Welsh population. The Children's oncology unit at the Children's Hospital for Wales (CHfW) is the only unit in Wales that provides treatment for children with complex haematological conditions (such as sickle cell anaemia or treatments requiring cell collection for re-infusion post chemotherapy). The unit works closely in partnership with the adult haematology department as the services are small and the processes required to manage the paediatric conditions are carried out rarely. Therefore education, training and maintaining competence are dependent on working in partnership with the adult service. The three Spectra Optia machines required to carry out apheresis, cell collection or cell processing procedures in this speciality are now of an age where they require replacement. The machine carries out highly specialist processes so they have to be reliable and accurate. This notice is for the purchase of three Spectra Optia machines including maintenance for up to five years (after the one year warranty) and consumables.

Options: Up to five years for maintenance (after the one year warranty) and consumables.

Procurement Information

The apheresis service at Cardiff and Vale UHB provides: 1. Donor apheresis (collection of haematopoietic progenitor cells [HPC, A] and peripheral blood mononuclear cells for immediate therapeutic use as well as a precursor for manufacture into chimaeric antigen receptor (CAR) T-cells) [MNC, A] 2. Therapeutic apheresis including plasma exchange and red blood cell exchange NICE Medical Technologies Guidance [MTG28], published the 2nd March 2016 and updated August 2020, concluded, inter alia, that the Spectra Optia is effective for managing red blood cell exchange in managing sickle cell disease and further noted that use of the Spectra Optia is likely to result in significant cost savings in most patients with sickle cell disease. NICE further noted that adopting the Spectra Optia is estimated to result in cost savings per person per year. As a result of this Guidance, NHSE has adopted the Spectra Optia system for its apheresis services. Given the need to perform both donor and therapeutic apheresis, It is imperative that the chosen platform is able to perform both functions effectively and efficiently. The Spectra Optia is the only system to have been reviewed and approved by NICE [MTG28] for therapeutic red cell exchange with resultant savings to the NHS. This is a service provided to the Health Board's patient population with sickle cell disease. In addition, the Paediatrics department requires the same equipment throughout the Health Board to align with Adult services ensuring standardised patient treatment and care along with staff training. Any change in equipment would mean that staff would require retraining and through the initial transition there is a greater risk of use error due to unfamiliarity. On the above basis, the Health Board is issuing this notice and applying a 10 day standstill period prior to award of the purchase of three machines and a contract for up to five years for maintenance (after the one year warranty) and consumables.

Publication & Lifecycle

Open Contracting ID
ocds-kuma6s-127796
Publication Source
Sell2Wales
Latest Notice
https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=127796
Current Stage
Award
All Stages
Award

Procurement Classification

Notice Type
OJEU - F3 - Contract Award Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Limited
Procurement Method Details
Award procedure without prior publication of a call for competition
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33140000 - Medical consumables

33194210 - Blood-transfusion devices

Notice Value(s)

Tender Value
Not specified
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
£400,000 £100K-£500K

Notice Dates

Publication Date
11 Jan 20233 years ago
Submission Deadline
Not specified
Future Notice Date
Not specified
Award Date
29 Dec 20223 years ago
Contract Period
Not specified - Not specified
Recurrence
Not specified

Notice Status

Tender Status
Cancelled
Lots Status
Cancelled
Awards Status
Unsuccessful
Contracts Status
Active

Contracting Authority (Buyer)

Main Buyer
NHS WALES SHARED SERVICES PARTNERSHIP
Contact Name
Laura Perrott
Contact Email
emma.lane@wales.nhs.uk, laura.perrott@wales.nhs.uk
Contact Phone
+44 02921836450, +44 1443848585

Buyer Location

Locality
CARDIFF
Postcode
CF14 4HH
Post Town
Cardiff
Country
Wales

Major Region (ITL 1)
TLL Wales
Basic Region (ITL 2)
TLL5 South East Wales
Small Region (ITL 3)
TLL51 Central Valleys and Bridgend
Delivery Location
TLL22 Cardiff and Vale of Glamorgan

Local Authority
Rhondda Cynon Taf
Electoral Ward
Taff's Well
Westminster Constituency
Cardiff North

Supplier Information

Number of Suppliers
1
Supplier Name

TERUMO BCT

Further Information

Notice Documents

  • https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=DEC422913
    Purchase of Apheresis Spectra Optia machines with maintenance and consumables - NHS Wales Shared Services Partnership who are hosted by Velindre NHS Trust acting on behalf of Cardiff and Vale University Local Health Board wish to inform the market that they intend to award a contract for the purchase of three Apheresis Spectra Optia machines with maintenance and consumables.
  • https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=JAN423679
    Purchase of Apheresis Spectra Optia machines with maintenance and consumables - NHS Wales Shared Services Partnership who are hosted by Velindre NHS Trust acting on behalf of Cardiff and Vale University Local Health Board wish to inform the market that they intend to award a contract for the purchase of three Apheresis Spectra Optia machines with maintenance and consumables.

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-kuma6s-127796-2023-01-11T00:00:00Z",
    "date": "2023-01-11T00:00:00Z",
    "ocid": "ocds-kuma6s-127796",
    "initiationType": "tender",
    "parties": [
        {
            "id": "org-6",
            "name": "NHS Wales Shared Services Partnership",
            "identifier": {
                "legalName": "NHS Wales Shared Services Partnership"
            },
            "address": {
                "streetAddress": "Procurement Services, Cardiff and Vale University Local Health Board, Woodlands House, Maes-Y-Coed Road",
                "locality": "Cardiff",
                "region": "UK",
                "postalCode": "CF14 4HH"
            },
            "contactPoint": {
                "email": "emma.lane@wales.nhs.uk",
                "telephone": "+44 02921836450"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://www.procurement.wales.nhs.uk"
            }
        },
        {
            "id": "org-7",
            "name": "Terumo BCT Ltd",
            "identifier": {
                "legalName": "Terumo BCT Ltd"
            },
            "address": {
                "streetAddress": "Old Belfast , Millbrook",
                "locality": "Larne",
                "region": "UKN0",
                "postalCode": "BT402SH"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        },
        {
            "id": "org-3",
            "name": "High Court",
            "identifier": {
                "legalName": "High Court"
            },
            "address": {
                "streetAddress": "Royal Courts of Justice, The Strand",
                "locality": "London",
                "postalCode": "WC2A 2LL"
            },
            "contactPoint": {
                "telephone": "+44 2079477501"
            },
            "roles": [
                "reviewBody"
            ]
        },
        {
            "id": "org-89",
            "name": "NHS Wales Shared Services Partnership",
            "identifier": {
                "legalName": "NHS Wales Shared Services Partnership"
            },
            "address": {
                "streetAddress": "4-5 Charnwood Court,, Heol Billingsley, Parc Nantgarw",
                "locality": "Cardiff",
                "region": "UK",
                "postalCode": "CF15 7QZ"
            },
            "contactPoint": {
                "name": "Laura Perrott",
                "email": "laura.perrott@wales.nhs.uk",
                "telephone": "+44 1443848585"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "classifications": [
                    {
                        "id": "Body governed by public law",
                        "scheme": "TED_CA_TYPE"
                    },
                    {
                        "id": "07",
                        "description": "Health",
                        "scheme": "COFOG"
                    }
                ],
                "url": "http://nwssp.nhs.wales/ourservices/procurement-services/"
            }
        },
        {
            "id": "org-17",
            "name": "High Court",
            "identifier": {
                "legalName": "High Court"
            },
            "address": {
                "streetAddress": "Royal Courts of Justice, The Strand",
                "locality": "London",
                "postalCode": "WC2A 2LL"
            },
            "contactPoint": {
                "telephone": "+44 2079477501"
            },
            "roles": [
                "reviewBody"
            ]
        }
    ],
    "buyer": {
        "name": "NHS Wales Shared Services Partnership",
        "id": "org-89"
    },
    "tender": {
        "id": "ocds-kuma6s-127796-tender-128018-CAV-STA (22-23) 5",
        "title": "Purchase of Apheresis Spectra Optia machines with maintenance and consumables",
        "description": "NHS Wales Shared Services Partnership who are hosted by Velindre NHS Trust acting on behalf of Cardiff and Vale University Local Health Board wish to inform the market that they intend to award a contract for the purchase of three Apheresis Spectra Optia machines with maintenance and consumables.",
        "status": "cancelled",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "id": "33194210",
                        "scheme": "CPV"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UKL22"
                    },
                    {
                        "region": "UKL22"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
        "procurementMethodRationale": "The apheresis service at Cardiff and Vale UHB provides: 1. Donor apheresis (collection of haematopoietic progenitor cells [HPC, A] and peripheral blood mononuclear cells for immediate therapeutic use as well as a precursor for manufacture into chimaeric antigen receptor (CAR) T-cells) [MNC, A] 2. Therapeutic apheresis including plasma exchange and red blood cell exchange NICE Medical Technologies Guidance [MTG28], published the 2nd March 2016 and updated August 2020, concluded, inter alia, that the Spectra Optia is effective for managing red blood cell exchange in managing sickle cell disease and further noted that use of the Spectra Optia is likely to result in significant cost savings in most patients with sickle cell disease. NICE further noted that adopting the Spectra Optia is estimated to result in cost savings per person per year. As a result of this Guidance, NHSE has adopted the Spectra Optia system for its apheresis services. Given the need to perform both donor and therapeutic apheresis, It is imperative that the chosen platform is able to perform both functions effectively and efficiently. The Spectra Optia is the only system to have been reviewed and approved by NICE [MTG28] for therapeutic red cell exchange with resultant savings to the NHS. This is a service provided to the Health Board's patient population with sickle cell disease. In addition, the Paediatrics department requires the same equipment throughout the Health Board to align with Adult services ensuring standardised patient treatment and care along with staff training. Any change in equipment would mean that staff would require retraining and through the initial transition there is a greater risk of use error due to unfamiliarity. On the above basis, the Health Board is issuing this notice and applying a 10 day standstill period prior to award of the purchase of three machines and a contract for up to five years for maintenance (after the one year warranty) and consumables.",
        "mainProcurementCategory": "goods",
        "documents": [
            {
                "id": "DEC422913",
                "documentType": "awardNotice",
                "title": "Purchase of Apheresis Spectra Optia machines with maintenance and consumables",
                "description": "NHS Wales Shared Services Partnership who are hosted by Velindre NHS Trust acting on behalf of Cardiff and Vale University Local Health Board wish to inform the market that they intend to award a contract for the purchase of three Apheresis Spectra Optia machines with maintenance and consumables.",
                "url": "https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=DEC422913",
                "format": "text/html"
            },
            {
                "id": "JAN423679",
                "documentType": "awardNotice",
                "title": "Purchase of Apheresis Spectra Optia machines with maintenance and consumables",
                "description": "NHS Wales Shared Services Partnership who are hosted by Velindre NHS Trust acting on behalf of Cardiff and Vale University Local Health Board wish to inform the market that they intend to award a contract for the purchase of three Apheresis Spectra Optia machines with maintenance and consumables.",
                "url": "https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=JAN423679",
                "format": "text/html"
            }
        ],
        "lots": [
            {
                "id": "1",
                "description": "The South Wales Blood and Marrow Transplant Programme (SWBMT) serves adults and children within the catchment area of mid, west and south Wales, comprising six of the seven Welsh Local Health Boards (LHBs), with a combined population of approximately 2.4 million and accounting for over three-quarters of the Welsh population. The Children's oncology unit at the Children's Hospital for Wales (CHfW) is the only unit in Wales that provides treatment for children with complex haematological conditions (such as sickle cell anaemia or treatments requiring cell collection for re-infusion post chemotherapy). The unit works closely in partnership with the adult haematology department as the services are small and the processes required to manage the paediatric conditions are carried out rarely. Therefore education, training and maintaining competence are dependent on working in partnership with the adult service. The three Spectra Optia machines required to carry out apheresis, cell collection or cell processing procedures in this speciality are now of an age where they require replacement. The machine carries out highly specialist processes so they have to be reliable and accurate. This notice is for the purchase of three Spectra Optia machines including maintenance for up to five years (after the one year warranty) and consumables.",
                "status": "cancelled",
                "options": {
                    "description": "Up to five years for maintenance (after the one year warranty) and consumables."
                },
                "hasOptions": true,
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "quality",
                            "name": "as per procurement docs",
                            "description": "100"
                        },
                        {
                            "type": "price",
                            "description": "0"
                        }
                    ]
                }
            }
        ],
        "coveredBy": [
            "GPA"
        ],
        "procurementMethodRationaleClassifications": [
            {
                "id": "D_OUTSIDE_SCOPE",
                "description": "The procurement falls outside the scope of application of the directive"
            }
        ],
        "classification": {
            "id": "33140000",
            "scheme": "CPV"
        },
        "reviewDetails": "NHS Wales Shared Services Partnership on behalf of Cardiff and Vale University Health Board will allow a minimum 10 calendar day standstill period between notifying the award decision and awarding the contract.",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        }
    },
    "awards": [
        {
            "id": "ocds-kuma6s-127796-award-127796-3",
            "suppliers": [
                {
                    "id": "org-7",
                    "name": "Terumo BCT Ltd"
                }
            ],
            "relatedLots": [
                "1"
            ]
        },
        {
            "id": "ocds-kuma6s-127796-award-128018-121",
            "status": "unsuccessful",
            "statusDetails": "discontinued",
            "relatedLots": [
                "1"
            ]
        }
    ],
    "contracts": [
        {
            "id": "ocds-kuma6s-127796-award-127796-3",
            "awardID": "ocds-kuma6s-127796-award-127796-3",
            "status": "active",
            "value": {
                "amount": 400000,
                "currency": "GBP"
            },
            "dateSigned": "2022-12-29T00:00:00Z"
        }
    ],
    "language": "EN",
    "description": "The value stated in this notice is the higher ceiling contract figure and may not be fully utilised as this will be dependent upon the volume of consumables ordered and maintenance years taken up. (WA Ref:128018)",
    "links": [
        {
            "rel": "canonical",
            "href": "https://api.sell2wales.gov.wales/v1?lang=cy/Notice?id=ocds-kuma6s-127796"
        }
    ],
    "noticetype": "OJEU - F3 - Contract Award Notice",
    "relatedProcesses": [
        {
            "id": "1",
            "relationship": [
                "planning"
            ],
            "scheme": "EU-OJ",
            "identifier": "2022/S 000-036674"
        }
    ]
}